Lembit Rägo

COVID-19 and risks to the supply and quality of tests, drugs, and vaccines

Paul N. Newton, Katherine C. Bond, Moji Christianah Adeyeye et al. · The Lancet Global Health · 2020 · 167 citations · Full text

Veterinary Medicine, Infectious Disease Control, Infectious Diseases +10

Discovery of a Novel Superpotent and Selective Melanocortin-4 Receptor Antagonist (HS024): Evaluation in Vitro and in Vivo**This work was supported by grants from the Swedish Medical Research Council (04X-05957), the Swedish Society for Medical Research, and the Estonian Science Foundation (Grant 3267); the Ants ja Maria Silvere ning Sigfried Panti Malestusstipendium Foundation (to A.K.); and the Swedish Institute (to I.M.).

Ants Kask, Felikss Mutulis, Ruta Muceniece et al. · Endocrinology · 1998 · 155 citations

Medicine, Medicinal Chemistry, Pharmacology +11

Twenty-five years of essential medicines.

Jonathan D. Quick, Hans V. Hogerzeil, Germán Velásquez et al. · PubMed · 2002 · 136 citations

Public Affairs, Pharmaceutical Policy, Pharmacology +12

Selective Antagonist for the Melanocortin 4 Receptor (HS014) Increases Food Intake in Free-Feeding Rats

Ants Kask, Lembit Rägo, Felikss Mutulis et al. · Biochemical and Biophysical Research Communications · 1998 · 130 citations

Medicine, Neuroscience, Pharmacology +13

Evidence for involvement of neuropeptide Y receptors in the regulation of food intake: studies with Y₁‐selective antagonist BIBP3226

Ants Kask, Lembit Rägo, Jaanus Harro · British Journal of Pharmacology · 1998 · 119 citations · Full text

Medicine, Neuroscience, Pharmacology +14